Acquisition of TheraPharm GmbH - Investor Call
Filed with ASX · · 1 page · English
Telix Pharmaceuticals Limited on 6ix
In the deck
Story so far
Earlier from Telix Pharmaceuticals
- Telix Acquires TheraPharm GmbH
- Prostate Cancer Therapy FDA Meeting Update
- NDA for Prostate Cancer Imaging accepted by US FDA
- Investor Briefing - Asia Strategy
- Strategic Licence and Partnership for Greater China Market
Later from Telix Pharmaceuticals
- Briefing for Investor call - TheraPharm GmbH Acquisition
- Telix and DuChemBio - South Korea Partnership
- ProstACT Phase III Study Clinical Development Update
- TGA Priority Review Granted for Prostate Cancer Imaging
- FDA New Drug Application for TLX591-CDx Proceeds to Review
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals